Adare is a global specialty pharmaceutical company inspired to improve the lives of patients whose treatment needs are not fully addressed by current medications. We use our unique combination of experience, proprietary capabilities, and resources to create meaningful products for them.
Our entrepreneurial and performance-driven culture encourages us to take risks, identify promising ideas, and see those opportunities through to completion. Our collaborative spirit and dedication to developing strong partnerships provide Adare and our partners with significant advantages in competitive markets.
Adare is a high-growth company with a long history of success from concept through commercialization. Our ability to create differentiated drugs guides the identification and development of the novel products in our pipeline and our acquisition strategy.
Our growth strategy is to develop and commercialize specialty products by:
- Developing and expanding our robust pipeline
- Growing our microbiome franchise
- Continuing to build strong development and commercial partnerships
- Executing strategic and disciplined acquisitions
Our Business Model
By unifying three core strategies, Adare develops differentiated pharmaceutical products that meet unmet patient needs. Our broad range of proprietary technologies and product development expertise give us the ability to help our partners develop unique products that expand their portfolios. Using our extensive knowledge of the healthcare industry, we identify valuable product opportunities and engage in full-scale clinical product development, with the intent to commercialize products for ourselves in select markets, or out-license these products to our partners.
Adare is built on a legacy of success. Although we have continued to evolve through the years, our knowledge and expertise have allowed us to consistently deliver innovative solutions in a challenging healthcare environment.